Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

5.29
-0.2300-4.17%
Post-market: 5.27-0.0200-0.38%19:58 EDT
Volume:1.94M
Turnover:10.51M
Market Cap:238.04M
PE:-2.44
High:5.72
Open:5.54
Low:5.27
Close:5.52
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:0.84
T/O Rate:11.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:0.90
PE(LYR):-2.81

Loading ...

Sionna Therapeutics Q2 EPS $(0.66) Misses $(0.65) Estimate

Benzinga Earnings
·
Aug 06

Sionna Net Loss Widens 65.43% to $29.89 Million in Q2 FY26

Reuters
·
Aug 06

Sionna Therapeutics Inc Q2 Basic EPS USD -0.66

THOMSON REUTERS
·
Aug 06

Sionna Therapeutics Inc Q2 Operating Expenses USD 32.47 Million

THOMSON REUTERS
·
Aug 06

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
Jul 27

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 20

Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns

Simply Wall St.
·
Jul 19

Sionna Therapeutics rises 9.2%

TIPRANKS
·
Jul 18

Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million

Reuters
·
Jul 10

Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of 10,250 Common Shares Worth $446,862.08

Reuters
·
Jul 08

Orbimed Advisors Disposes of 115,844 Sionna Therapeutics Shares Worth $5.27 Million

Reuters
·
Jul 03

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Jun 25

Sionna Therapeutics: Buy Rating Reiterated on NBD1-Focused CF Strategy; $60 Price Target Maintained

TIPRANKS
·
Jun 22

Sionna Therapeutics shareholders elect Class II directors at annual meeting

Reuters
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 11

OrbiMed Advisors reports Sionna Therapeutics common stock sale valued at $4,493.49

Reuters
·
May 30

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences

GlobeNewswire
·
May 27

Sionna Therapeutics Price Target Maintained With a $63.00/Share by Citizens

Dow Jones
·
May 26

Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 25